Brentuximab vedotin demonstrates significant clinical activity in relapsed or refractory mycosis fungoides with variable CD30 expression Meeting Abstract
| Authors: | Krathen, M.; Sundram, U.; Bashey, S.; Sutherland, K.; Salva, K.; Wood, G. S.; Advani, R. H.; Hoppe, R. T.; Reddy, S.; Armstrong, R.; Nagpal, S.; Pulitzer, M.; Horwitz, S. M.; Kim, Y. H. |
| Abstract Title: | Brentuximab vedotin demonstrates significant clinical activity in relapsed or refractory mycosis fungoides with variable CD30 expression |
| Meeting Title: | 54th Annual Meeting and Exposition of the American Society of Hematology (ASH) |
| Journal Title: | Blood |
| Volume: | 120 |
| Issue: | 21 |
| Meeting Dates: | 2012 Dec 8-11 |
| Meeting Location: | Atlanta, GA |
| ISSN: | 0006-4971 |
| Publisher: | American Society of Hematology |
| Date Published: | 2012-11-01 |
| Language: | English |
| ACCESSION: | WOS:000313838900162 |
| PROVIDER: | wos |
| DOI: | 10.1182/blood.V120.21.797.797 |
| Notes: | --- - Meeting Abstract: 797 - 54th Annual Meeting and Exposition of the American-Society-of-Hematology (ASH) - DEC 08-11, 2012 - Atlanta, GA - "Source: Wos" |
Altmetric
Citation Impact
BMJ Impact Analytics
